Early detection of renal pelvic tumor is essential since the survival rate is markedly reduced if the lesion has invaded beyond the pelvic wall. Accurate preoperative diagnosis is of considerable practical importance. since the surgeon should choose an unique operative approach conducive to a nepbroureterectomy with removal of a cuff of bladder. Selective renal angiography plays an important role in the diagnosis of renal tumor, but little is known about the importance of selective renal angiography in renal pelvic tumor. We performed selective renal angiography in 9 patients with clinically diagnosed renal pelvic tumor in this department during 2 years and 4 months period from March 1979 to June 1981. 7 out of 9 patients were diagnosed with transitional cell carcinoma of the renal pelvis histologically and remaining 2, leiomyoma of the renal parenchyma and renal cell carcinoma. The angiographic findings in 7 patients with transitional cell carcinoma showed hypertrophy of the pelviureteral artery and a diminished branching of vessels in 5, respectively, and defects in the nephrographic phase, neovascularity and vascular displacement in 2 each.
Angiography ; Arteries ; Carcinoma, Renal Cell ; Carcinoma, Transitional Cell ; Diagnosis ; Humans ; Hypertrophy ; Kidney Pelvis ; Leiomyoma ; Survival Rate ; Urinary Bladder

A clinical observation was made on patients with the tumors of the genitourinary tract, who were admitted to the Department of Urology, Kyungpook National University Hospital during 10 years period from January 1970 to December 1979. Out of 1606 total hospital admissions. 284 were due to the tumors of the genitourinary tract, giving rate of 17.68%, sex ratio, male to female, was 6.89:1 The most frequently involved age group was the 7th decade, being 31% of total, followed by the 6th decade (22%). About 85.21% was seen at age of 40 and over. Prostate was the most commonly involved organ comprising 122 (42.96%) out of 284 cases of the tumors of the genitourinary tract, followed in frequency by bladder in 77 (27.11%), kidney in 40 (14.08%), and penis in 24 (8.45%). The tumors were benign in 123 and malignant in 161, giving ratio of benign to malignant approximately 1:1.3. The most common type among benign group was B.P.H. and among malignant type, bladder carcinoma. Pathologic diagnosis was performed on 174 cases. Out of these, 52 were diagnosed as transitional cell carcinoma of bladder, followed in frequency by B.P.H. in 36 and squamous cell carcinoma of penis in 16.
Carcinoma, Squamous Cell ; Carcinoma, Transitional Cell ; Diagnosis ; Female ; Gyeongsangbuk-do ; Humans ; Kidney ; Male ; Penis ; Prostate ; Sex Ratio ; Urinary Bladder ; Urology

Right-sided varicocele is a relatively rare disease, which could be caused by retroperitoneal pathology, situs Inversus or ananomalous termination of the right internal spermatic vein into the right renal vein or the left renal vein. Herein we report a rare case of right-sided varicocele in a 31-year-old fertile man with situs inversus.
Adult ; Humans ; Pathology ; Rare Diseases ; Renal Veins ; Situs Inversus* ; Varicocele* ; Veins

Renal cell carcinoma in children has been considered a rare clinical entity but perhaps not as rare as once thought. This neoplasm should be considered in the differential diagnosis of hematuria and/or abdominal masses in children. Herein two cases of histologically proven childhood renal cell carcinoma are presented.
Carcinoma, Renal Cell* ; Child* ; Diagnosis, Differential ; Hematuria ; Humans

A rare case of benign hemorrhagic renal cyst ruptured into the pyelocaliceal system, which occurred in a 44-year-old male, is presented. The literature is reviewed briefly.
Adult ; Hemorrhage ; Humans ; Male

In systemic lupus erythematosus patients, prevalence of renal involvement is high, even in the absence of overt clinical manifestation. Lupus nephritis can usually be categorized according to the widely used WHO classification. however, clinically significant renal disease unrelated to lupus nephritis have rarely been described in patients with SLE. Especially, there has been few reported cases of IgA nephropathy with SLE since first reported in 1995, but their relationship is not apparent yet. We experienced a 72-year-old female who was admitted to our hospital due to generalized edema, arthralgia, proteinuria, microscopic hematuria. Her diagnosis of IgA nephropathy was estabilished on biopsy. At the same time, she was diagnosed as SLE. in that the serology for ANA was positive at 1:640, lupus anticoagulant and anti-cardiolipin antibody were positive, hemolytic anemia, arthritis and oral ulcer. and eventually she was diagnosed end-stage renal disease 2 months later. In conclusion, atypical glomerular lesion in SLE should raise the possibility of a non-lupus glomerulopathy, including IgA nephropathy.
Aged ; Anemia, Hemolytic ; Arthralgia ; Arthritis ; Biopsy ; Classification ; Diagnosis ; Edema ; Female ; Glomerulonephritis ; Glomerulonephritis, IGA* ; Hematuria ; Humans ; Immunoglobulin A* ; Kidney Failure, Chronic ; Lupus Coagulation Inhibitor ; Lupus Erythematosus, Systemic* ; Lupus Nephritis ; Oral Ulcer ; Prevalence ; Proteinuria

BACKGROUND/AIMS: The aims of this study were to identify real world treatment patterns of hypertension according to cardiovascular risk stratification and to evaluate blood pressure changes with anti-hypertensive treatment in each risk group. METHODS: This study included patients who were newly-diagnosed with hypertension or known hypertensive patients with uncontrolled blood pressure (BP) at seven tertiary hospitals in Busan and Ulsan. World Health Organization/International Society of Hypertension (WHO/ISH) cardiovascular risk stratification was performed through retrospective chart review. RESULTS: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers were the most frequently prescribed drugs. The higher WHO/ISH risk group received a greater number of drugs at the initial treatment, and one year after treatment. Target BP was achieved less frequently in the higher risk group (68.2% vs. 85.2% vs. 89.0%, p < 0.001). The rate of attaining target BP was lower (50.7% vs. 81.6%, p < 0.001), and the time to attaining target BP was longer (106.5 +/- 79.2 days vs. 82.1 +/- 75.3, p = 0.001), in patients with renal disease or diabetes. Initial systolic BP above 160 mmHg (OR: 4.91, 95% CI: 2.27~10.65), renal disease (3.42, 1.60~7.32), medium or high risk group status (2.27, 1.23~4.20), initial diastolic BP above 100 mmHg (2.11, 1.11~4.04), and diabetes (2.06, 1.29~3.25) were independent factors that predicted failure of attaining the target BP. CONCLUSIONS: BP control was relatively unsatisfactory in patients with higher initial BP, renal disease, higher WHO/ISH risk group status, and diabetes. Individualized approaches for such patients are needed to improve BP control in routine clinical practice.
Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Blood Pressure ; Humans ; Hypertension ; Retrospective Studies ; Risk Factors ; Tertiary Care Centers ; World Health ; World Health Organization

BACKGROUND AND OBJECTIVES: A higher neutrophil to lymphocyte ratio (NLR) has been associated with poor clinical outcomes in various cardiac diseases. However, the clinical availability of NLR in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) has not been known. We evaluated the availability of NLR to predict clinical outcomes in patients with STEMI undergoing primary PCI. SUBJECTS AND METHODS: We analyzed 326 consecutive STEMI patients treated with primary PCI. The patients were divided into tertiles according to NLR: NLR< or =3.30 (n=108), 3.316.53 (n=110). We evaluated the incidence of major adverse cardiac events (MACE), a composite of all causes of death, non-fatal MI, and ischemic stroke at the 12-month follow-up. RESULTS: The high NLR group was associated with a significantly higher rate of 12-month MACE (19.1% vs. 3.7%, p<0.001), 12-month death (18.2% vs. 2.8%, p<0.001), in-hospital MACE (12.7% vs. 2.8%, p=0.010) and in-hospital death (12.7% vs. 1.9%, p=0.003) compared to the low NLR group. In the multivariable model, high NLR was an independent predictor of 12-month MACE {hazard ratio (HR) 3.33 (1.09-10.16), p=0.035} and death {HR 4.10 (1.17-14.46), p=0.028} after adjustment for gender, left ventricular ejection fraction, creatinine clearance, angiographic parameters and factors included in the Thrombolysis in Myocardial Infarction risk score for STEMI. There was a significant gradient of 12-month MACE across the NLR tertiles with a markedly increased MACE hazard in the high NLR group (log rank test p=0.002). CONCLUSION: The NLR is a useful marker to predict 12-month MACE and death in patients with STEMI who have undergone primary PCI.
Cause of Death ; Creatinine ; Heart Diseases ; Humans ; Incidence ; Lymphocytes ; Myocardial Infarction ; Neutrophils ; Percutaneous Coronary Intervention ; Stroke ; Stroke Volume

A 55-year-old male patient presented with an acute myocardial infarction. A sirolimus-eluting stent (SES) was implanted in the proximal left anterior descending artery (LAD). Eight months later, there was a newly developed distal LAD lesion. An additional SES was implanted. Twenty-eight months after the index procedure of primary coronary intervention, the electrocardiogram showed ST elevation in the precordial leads and an emergency coronary angiogram showed diffuse stent thrombosis (ST) in the proximal LAD. Thirty-four months after the index procedure, coronary angiography showed a large peri-stent coronary aneurysm in the proximal LAD and focal in-stent restenosis (ISR) at the proximal edge of the distal LAD stent. On fluoroscopy, a fracture was noted in the middle part of the distal SES. A zotarolimus- eluting stent (ZES) was deployed and overlapped the restenosis and fracture sites. Forty months after the index procedure, there were no changes in the size of the aneurysm or in the other stent complications including the fracture and restenosis. At present, the patient has remained asymptomatic for eight months.
Aneurysm ; Arteries ; Coronary Aneurysm ; Coronary Angiography ; Drug-Eluting Stents ; Electrocardiography ; Emergencies ; Fluoroscopy ; Humans ; Male ; Middle Aged ; Myocardial Infarction ; Stents ; Thrombosis

Patients with hemophilia generally have a reduced frequency of coronary artery disease compared to the general population. As advances in the management of hemophilia have increased their life expectancy, the prevalence of coronary artery disease also has increased. However, there are no standard treatment guidelines for coronary artery disease in patients with hemophilia, especially in the field of coronary intervention. We report the case of a patient with severe hemophilia A who presented with acute coronary syndrome and was successfully treated with percutaneous coronary intervention.
Acute Coronary Syndrome ; Angioplasty ; Coronary Artery Disease ; Hemophilia A ; Humans ; Life Expectancy ; Percutaneous Coronary Intervention ; Prevalence